MeiraGTx Holdings plc
NASDAQ: MGTX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Alexandria Forbes
- Employees
- 375
- Headquarters
- New York City, United States
- IPO year
- 2018
- Market cap
- $1.1B
- Website
- https://www.meiragtx.com
Loading MGTX…
Loading profile data…Frequently asked questions about MGTX
What does MeiraGTx Holdings plc (MGTX) do?
MeiraGTx Holdings plc operates as a clinical-stage gene therapy company, dedicated to pioneering therapeutic solutions for individuals afflicted by serious illnesses. Its development efforts span a broad spectrum of conditions, encompassing ocular diseases like inherited forms of blindness, as well as xerostomia (dry mouth) that often follows ra...
Where does MGTX trade?
MeiraGTx Holdings plc (MGTX) trades on the NASDAQ Global Select.
What sector is MGTX in?
MeiraGTx Holdings plc (MGTX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of MeiraGTx Holdings plc?
Alexandria Forbes is the chief executive officer of MeiraGTx Holdings plc (MGTX).
Where is MeiraGTx Holdings plc headquartered?
MeiraGTx Holdings plc is headquartered in United States.
Does MGTX pay a dividend?
MeiraGTx Holdings plc (MGTX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MGTX go public?
MeiraGTx Holdings plc (MGTX) completed its initial public offering in 2018.